SAN DIEGO–(BUSINESS WIRE)–Sinopia Biosciences, Inc., a biotechnology company advancing novel therapeutics identified using its proprietary LEADS® drug discovery platform, announced today it has been awarded a research grant from the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health (NIH), to further advance its data-driven drug discovery capabilities. Omics technologies enable comprehensive characterization of cellular systems. This means phenot
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
